-
2025-521950-41-00
5
severe uncontrolled asthma
-
2025-522362-78-00
6
severely active ulcerative colitis (US) and CD (Crohn’s disease)
-
2025-523117-28-00
4
Relapsed or Refractory Multiple Myeloma
-
2025-523431-19-00
4
2026-05-20
Idiopathic Pulmonary Fibrosis (IPF)
-
2025-522896-27-00
4
2026-05-11
Asthma
-
2025-522484-15-00
5
2026-04-27
ER+/HER2- early breast cancer
-
2025-520982-39-00
5
2025-12-09
Philadelphia Chromosome Positive or ABL-class Philadelphia Chromosome-
-
2023-507402-13-00
5
2024-04-03
Multiple myeloma
-
2023-506414-46-00
5
2022-04-22
High risk patients defined as having at least one of the following ris
-
2025-521456-35-00
4
2026-04-13
Mild to moderate asthma
-
2025-522674-36-00
5
2026-03-24
Metabolic Dysfunction-Associated Steatotic Liver Disease
-
2024-519976-19-00
5
2025-11-26
Asthma with type 2 inflammation characterized by an eosinophilic pheno
-
2024-515561-34-01
6
2025-08-04
Acute ischemic stroke with recent ingestion of direct oral anticoagula
-
2024-518893-15-00
5
2025-07-29
Chronic lymphotic leukemia and Small Lymphocytic lymphoma
-
2024-517727-39-00
5
2025-07-28
Covid-19 at high risk of progression to severe illness.
-
2024-513959-33-00
4
2025-05-13
Asthma
-
2024-515162-13-00
5
2025-04-29
Eosinophilic Asthma
-
2023-509717-36-00
5
2024-12-16
AF patients who have undergone successful PCI
-
2024-514917-36-00
5
2024-11-21
Patients with High Risk Neuroblastoma
-
2022-502282-24-00
5
2024-02-14
Primary generalized tonic-clonic seizures
-
2024-517334-18-00
6
2022-04-06
Inflammatory or autoimmune disorders
-
2023-508302-24-00
4
2019-05-07
Locally Advanced/Metastatic Urothelial Cancer
-
2022-502878-16-00
5
2025-01-23
Acute ischemic strokes with incomplete reperfusion
-
2023-510279-80-00
4
2024-09-25
Prurigo nodularis